Piramal Critical Care (PCC), a business division of Piramal Pharma Limited (PPL) is a leader in inhaled anesthetics and a global player in hospital generics. “Saving and improving patients’ lives” is much more than a purpose statement to us. We are motivated by our vision of commitment to delivering critical care solutions for patients and healthcare providers, while achieving sustainable and profitable growth for all the stakeholders. Piramal Critical Care maintains a wide presence across the US, Europe and more than 100 countries across the globe. Our product portfolio includes inhalation anesthetics, intrathecal therapy for spasticity management, injectable pain and anesthesia drugs, injectable anti-infectives, oral therapy for Type I Gaucher and Niemann pick Type C disease, anticholinergic, plasma volume expander, non-depolarizing neuromuscular blocking agent, depolarizing skeletal muscle relaxant and an anxiolytic, sedative and pain medication. PCC has strong manufacturing and process development experience. PCC has fully owned manufacturing facilities in Bethlehem, PA, USA and Digwal, India. Customer centricity is the cornerstone of our business. *RTU Ready to use Please note that adverse effects for any of our products should be reported to: [email protected]
External link for Piramal Critical Care
Piramal Critical Care reposted this
Attention! We have recently come across a few instances of our brand name and logo being misused to mislead customers and vendors. We urge caution and vigilance against such deceptive practices. Protecting our integrity and your trust is paramount. Please connect with us for any queries, assistance or clarifications. #Vigilance #BrandIntegrity #CustomerAdvisory
Piramal Critical Care expands generic injectables portfolio with U.S. launch of new concentration of Zinc Sulfate for Injection, USP 10mg/10mL (1mg/mL). Piramal Critical Care, as always, is committed to serving our customers by offering a diverse and growing portfolio of products, including generic injectables, inhaled anesthesia and intrathecal therapy. Full Release: https://hubs.ly/Q02gCl4q0 #pharma #pharmanews #piramal #piramalcriticalcare
Piramal Critical Care looks forward to you joining us at ASHP Midyear Clinical Meeting in Anaheim this December. Visit us at at booth #1847. Will you be there? https://hubs.ly/Q028FyCM0 #ASHP23
Find Piramal Critical Care Intrathecal Therapy Team at Booth #655 for American Academy of Physical Medicine & Rehabilitation (AAPM&R) annual meeting and join our pop-up education session: Spasticity Management & The Impact of ITB Therapy presented by Dr Zachary Bohart on Friday, November 17th.
In partnership with Knack Pharmaceuticals, Piramal Critical Care announces the US launch of Pantoprazole Sodium for Injection, USP. Piramal Critical Care, as always, is committed to serving our US customers by offering a diverse and growing portfolio of products, including generic injectables, inhaled anesthesia and intrathecal therapy. #pharma #pharmanews #piramal #piramalcriticalcare
Piramal Critical Care is attending CPhI Worldwide 2023 at the Fira Barcelona-Gran Via, Spain from October 24th to 26th. Meet our team at booth no. 3L70. #CPhIWorldwide #PiramalCriticalCare #PiramalPharma
Piramal Critical Care is participating in the American Society of Anesthesiologists® (ASA) conference, being held from October 13-17, 2023 in San Francisco, CA. Visit us at booth #338 to learn more about our critical care product portfolio. https://hubs.ly/Q025w9ct0 #ANES23 #anesthesiology #anesthesiologist